TET2 and myelodysplastic syndrome: In particular, alterations in TET2—a regulator of cytosine methylation—have been detected frequently in myelodysplastic syndromes (MDS) and more recently have been reported to occur as secondary cytogenetic abnormalities in acute and blast phase CML [31].